@subi1
best to look when their debt is due to be repaid and calculate what is their cash burn right now. considering they shut the production of NdPr, I'd say their costs are up and on top of that they now most likely have fair bit of stock they need to get rid of. ASM is not really open on what happened during the delivery issue with this customer so it's very hard to tell the true cost to ASM.
In those situations, I always go with bigger cost hit to be on the safe side.
Also to consider is ASM can't leave it for too late and will have to make a move probably before cash goes below ~ $30m?? rough estimate. And considering how tough it is out there right now it will not be easy to attract capital.
we are seeing very big selling in ALK shares in recent days and coincided roughly with the selling in ASM - my own speculation is the market is betting IG will be forced to sell ALK shares to participate in future ASM CR. And I hope ALK selling is not related to anything else.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
@subi1 best to look when their debt is due to be repaid and...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASM (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.5¢ |
Change
-0.025(4.39%) |
Mkt cap ! $98.81M |
Open | High | Low | Value | Volume |
57.0¢ | 57.0¢ | 54.0¢ | $93.62K | 170.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 699 | 54.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 2890 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 699 | 0.545 |
3 | 11720 | 0.540 |
2 | 54699 | 0.535 |
5 | 48937 | 0.530 |
3 | 18500 | 0.525 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 2890 | 1 |
0.565 | 926 | 1 |
0.570 | 127218 | 4 |
0.575 | 8766 | 1 |
0.580 | 28039 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ASM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online